Skip to main content
Log in

Low-dose CT screening for lung cancer cost effective in smokers

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • McLeod M, et al. Impact of low-dose CT screening for lung cancer on ethnic health inequities in New Zealand: a cost-effectiveness analysis. BMJ Open : 24 Sep 2020. Available from: URL: http://dx.doi.org/10.1136/bmjopen-2020-037145

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Low-dose CT screening for lung cancer cost effective in smokers. PharmacoEcon Outcomes News 863, 18 (2020). https://doi.org/10.1007/s40274-020-7172-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7172-z

Navigation